Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tolperisone and tolperisone-like drugs for the treatment of Kras mutant cancers

Tolperisone and tolperisone-like drugs for the treatment of Kras mutant cancers. 2007.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.